Trial Profile
A Multinational, Prospective, Observational study of Teriparatide in Postmenopausal women with Osteoporosis in Asia & Latin America
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 May 2018
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Fracture; Postmenopausal osteoporosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms ALAFOS
- 23 May 2018 New trial record
- 22 Apr 2018 Trial design presented at the 2018 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases